Debiopharm Group™ (Debiopharm) is a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative therapies that target unmet medical needs. The group in-licenses -from partners all over the world-, develops and/or co-develops promising biologics, siRNAs and small molecule drug candidates having reached clinical development phases I, II or III as well as earlier stage candidates. It develops its products for global registration. The products are out-licensed to pharmaceutical partners for worldwide sales and marketing. Debiopharm is active in the field of companion diagnostics with a view to progressing in the area of personalised medicine. Debiopharm independently funds the worldwide development of all of its products while providing expertise in pre-clinical and clinical trials, manufacturing, drug delivery and formulation, and regulatory affairs. For more information on Debiopharm Group™, please visit our website.